NT-proBNP values in elderly heart failure patients with atrial fibrillation and diabetes
- 1 November 2015
- journal article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 29 (8), 1119-1123
- https://doi.org/10.1016/j.jdiacomp.2015.08.013
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapiesInternational Journal of Cardiology, 2015
- Concomitant Diabetes Mellitus and Heart FailureCurrent Problems in Cardiology, 2014
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEP Europace, 2012
- Diabetes Mellitus, Glycemic Control, and Risk of Atrial FibrillationJournal of General Internal Medicine, 2010
- Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE studyEuropean Heart Journal, 2009
- Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial)The American Journal of Cardiology, 2008
- Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failureDiabetic Medicine, 2007
- The diabetes epidemic: a national and global crisisAmerican Journal Of Medicine, 2004
- Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With DiabetesDiabetes Care, 2003
- Independent Risk Factors for Atrial Fibrillation in a Population-Based CohortJama-Journal Of The American Medical Association, 1994